MyAverix Finance
SHG · Healthcare
Kangmei Pharmaceutical Co Ltd (600518)
Drug Manufacturers - Specialty & Generic
Kangmei Pharmaceutical Co Ltd (600518) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600518
Kangmei Pharmaceutical Co Ltd (600518) — FAQ
What is 600518's P/E ratio?
The price-to-earnings (P/E) ratio for Kangmei Pharmaceutical Co Ltd (600518) is 18.00 (data as of 2026-05-21).
Does Kangmei Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Kangmei Pharmaceutical Co Ltd (600518). Check the MyAverix Finance app for the latest dividend data.
What sector is Kangmei Pharmaceutical Co Ltd in?
Kangmei Pharmaceutical Co Ltd (600518) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600518 listed on?
600518 is listed on SHG.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.